Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is -1.08% vs -6.36% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -42.39% vs -45.94% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 4.90% vs -24.83% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 16.13% vs 20.47% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Towa Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -1.08% vs -6.36% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 4.13% vs 14.70% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -42.39% vs -45.94% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -54.27% vs 15.68% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 4.90% vs -24.83% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 0.46% vs 24.50% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 16.13% vs 20.47% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 63.14% vs 72.40% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






